Back to dashboard
Episode 28
DIP Episode 28 - Antibiotics Part 2 (Protein Synthesis Inhibitors)
MixedMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Protein synthesis inhibitors (Aminoglycosides, Tetracyclines, Macrolides, Lincosamides, Oxazolidinones); Antibiotic mechanisms of action...
Key Takeaway
Antibiotics targeting protein synthesis are classified by their ribosomal binding site (30S or 50S subunit) and mechanism (e.g., inhibiting translocation vs. peptidyl transferase), leading to distinct coverage patterns, toxicities, and drug-drug interactions via P450 metabolism.
Runtime: 34.2 min
Published: 2018-05-13
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: MICROBIOLOGY, PHARMACOLOGY
Episode Notes
Source / episode info
- Episode: 28
- Title: Divine Intervention Episode 28 – Antibiotics Part 2 (Protein Synthesis Inhibitors).
- Published: 2018-05-13
- Source: Episode page
One-liner
This episode details antibiotics that inhibit protein synthesis by targeting the bacterial ribosome (70 S), focusing on drugs like aminoglycosides (30 S inhibitors), macrolides/lincosamides (50 S inhibitors), and tetracyclines (A-site inhibitors), while reviewing associated toxicities, coverage patterns, and P450 metabolism.
High-yield summary
- Aminoglycosides (Gentamicin, Neomycin, Amikacin): 30 S inhibitors; cover primarily Gram-negative rods; nephrotoxic (ototoxicity/nephrotoxicity); no anaerobic coverage; used for GI flora control in HE.
- Macrolides/Lincosamides (Azithromycin, Clindamycin, Linezolid): 50 S inhibitors; inhibit translocation; Macrolides are associated with GI upset and risk of pyloric stenosis; Lincosamides (Clindamycin) cover anaerobes above the diaphragm.
- Tetracyclines (Doxycycline, Minocycline): 30 S inhibitors; broad spectrum; contraindicated in children <8 years old due to chelation by divalent ions leading to tooth/bone discoloration.
- Chloramphenicol: Potent Gram-positive and Gram-negative coverage; used for severe infections (e.g., meningitis, RMSF in pregnant women); toxic due to inhibition of UDPGT, causing aplastic anemia and Gray baby syndrome in neonates.
- P450 Metabolism: Macrolides are P450 inhibitors; Rifampin is a potent P450 inducer. This interaction is critical for drug dosing (e.g., birth control failure).
Learning objectives
- Differentiate between 30 S and 50 S ribosomal inhibitors, naming key drugs for each class.
- Correlate specific antibiotic classes with their primary coverage (e.g., aminoglycosides vs. anaerobes).
- Recognize the unique toxicities associated with high-yield antibiotics (Chloramphenicol, Macrolides, Aminoglycosides).
- Understand the clinical implications of P450 enzyme induction and inhibition by various drugs.
- Apply antibiotic knowledge to common infectious scenarios like C. difficile colitis or Lyme disease.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| C. difficile Colitis | Pseudomembrane formation; Diarrhea | Clostridioides difficile overgrowth | Treat with Vancomycin (oral) or Fidaxomicin. Metronidazole is often insufficient for severe cases. |
| Lyme Disease (Borrelia burgdorferi) | Tick bite history, erythema migrans rash | Tetracyclines (Doxycycline) | Doxycycline is the drug of choice; remember that tetracyclines are generally contraindicated in children <8 years old due to staining risk. |
| Neonatal Toxicity | Aplastic anemia, Gray baby syndrome | Chloramphenicol | Due to deficiency of UDPGT enzyme activity in newborns. Use only when absolutely necessary (e.g., RMSF). |
| Pyloric Stenosis | Non-bilious projectile vomiting (<8 weeks old) | Macrolides (Azithromycin/Erythromycin) | These antibiotics are associated with increased risk of pyloric stenosis, especially in the first 8 weeks of life. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Aminoglycosides | 30 S inhibitors; Gram-negative only | Treating severe sepsis/Gram-negative infections | Nephrotoxic (ototoxicity, nephrotoxicity); no anaerobic coverage. |
| Macrolides | 50 S inhibitors; Translocation inhibition | Treating respiratory or skin infections | GI upset is common; risk of pyloric stenosis in neonates. |
| Lincosamides | 50 S inhibitors; Anaerobe coverage | Aspiration pneumonia/GI flora overgrowth | Clindamycin provides excellent anaerobic coverage above the diaphragm. |
| P450 Metabolism | Induction vs. Inhibition | Drug-drug interactions (e.g., birth control failure) | Rifampin is a potent inducer; Macrolides are inhibitors. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with severe diarrhea and suspected overgrowth of gut flora, particularly in the setting of abdominal surgery or immunosuppression. | Clindamycin (Lincosamide) | It is a potent inhibitor of bacterial protein synthesis that has excellent coverage for anaerobes above the diaphragm. |
| A neonate presents with jaundice, lethargy, and elevated bilirubin following administration of an antibiotic. | Chloramphenicol toxicity / Gray baby syndrome | Neonates have impaired UDPGT activity, leading to accumulation of chloramphenicol metabolites and subsequent toxic effects on bone marrow and central nervous system. |
| A patient with suspected Lyme disease (Borrelia burgdorferi) presents after a tick bite. | Tetracycline class drugs (Doxycycline) | Tetracyclines are highly effective against Borrelia species, making them the drug of choice for early-stage Lyme disease. |
| A patient requires prophylaxis against methicillin-resistant Staphylococcus aureus (MRSA) skin infection. | Linezolid or Daptomycin (or other anti-MRSA agents) | Linezolid is an oxazolidinone that covers MRSA and VRE, offering a clean oral alternative to IV vancomycin. |
| A patient with suspected aspiration pneumonia has flora suggestive of anaerobic overgrowth. | Metronidazole or Clindamycin | Anaerobes are typically found above the diaphragm in aspiration pneumonias; these drugs provide targeted coverage for those organisms (e.g., Bacteroides, Fusobacterium). |
| A woman taking oral contraceptives develops breakthrough bleeding after starting a new antibiotic regimen. | P450 Induction/Inhibition Interaction | Antibiotics that are strong CYP enzyme inducers (like Rifampin) can reduce the effectiveness of hormonal contraception by accelerating drug metabolism. |
Differential diagnosis / distinguishing features
Antibiotic Toxicity and Contraindications
| Key Features | Distinguishing Findings | Next Step |
| Chloramphenicol | Aplastic anemia, Gray baby syndrome | Neonatal use is highly restricted; reserved for life-threatening infections (e.g., RMSF in pregnancy). |
| Tetracyclines | Chelation by divalent ions ({Ca}^{2+}, {Mg}^{2+}) | Contraindicated in children <8 years old due to permanent tooth/bone staining. |
| Macrolides | Increased risk of pyloric stenosis, GI upset | Avoid use in neonates and infants <8 weeks; monitor for signs of obstruction. |
Management pearls
- For suspected C. difficile colitis: Start with oral Vancomycin or Fidaxomicin. Metronidazole is often insufficient for severe disease.
- When treating aspiration pneumonia, remember the classic anaerobes (Bacteroides, Fusobacterium) are typically found above the diaphragm and require agents like Metronidazole or Clindamycin.
- In pregnant women with Rocky Mountain Spotted Fever (RMSF), Chloramphenicol is historically indicated despite its toxicity profile due to life-threatening maternal/fetal risk.
- If a patient has suspected Pseudomonas infection in CF, use an aminoglycoside like Amikacin or Gentamicin, as these drugs are excellent against Gram-negative rods.
Don't miss
🚨
The mechanism of action for macrolides (e.g., Azithromycin) is inhibiting the translocation step of protein synthesis on the 50 S subunit, which differs from lincosamides or chloramphenicol.
🚨
Aminoglycosides are highly nephrotoxic and ototoxic; monitor renal function closely when administering these drugs.
🚨
The P450 enzyme system dictates drug interactions: Rifampin is a potent inducer, while macrolides (e.g., Azithromycin) are inhibitors.
Integration & clinical reasoning
- Pharmacology & Biochemistry: Understanding the structure of the ribosome (70 S bacterial vs 80 S human) and the specific subunits (30 S/50 S) is foundational to understanding antibiotic targets.
- Infectious Disease & Toxicology: The use of antibiotics must be balanced against their toxicities; for example, using chloramphenicol in neonates requires weighing the risk of Gray baby syndrome against the severity of the infection.
- Pharmacology & Endocrinology (P450): P450 metabolism is a key concept linking multiple drug classes. Understanding induction/inhibition helps predict therapeutic failure or toxicity when combining medications (e.g., oral contraceptives and Rifampin).
Concept connections / cross-references
- For detailed information on the mechanism of action of antibiotics, see [Episode 27].
- The principles of P450 metabolism are discussed in detail regarding drug interactions in [Episode 39].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Aminoglycosides | Nephrotoxicity/Ototoxicity | Damage to renal tubules and cochlea | Requires careful monitoring of creatinine, BUN, and hearing checks. |
| Macrolides | Pyloric Stenosis Risk | Interference with gut motility/GI tract function | Avoid use in neonates and infants <8 weeks old; monitor for projectile vomiting. |
| Tetracyclines | Bone/Tooth Discoloration | Chelation by divalent ions ({Ca}^{2+}, {Mg}^{2+}) | Contraindicated in children <8 years old due to irreversible staining of developing teeth and bone. |
| Rifampin | P450 Induction | Induces CYP enzymes (e.g., CYP3 A4) | Can drastically reduce the effectiveness of oral contraceptives, leading to unintended pregnancy. |
Key terms glossary
| Term | Definition | Context | Example |
| Aminoglycosides | Class of antibiotics targeting 30 S ribosomal subunit. | Bacterial protein synthesis inhibition. | Gentamicin, Amikacin (Gram-negative coverage). |
| Translocation | Sub-step in protein synthesis where tRNA moves from A to P site. | Inhibited by Macrolides and Lincosamides. | Azithromycin prevents the ribosome from moving along mRNA. |
| UGPT Deficiency | Deficiency of UDP-glucuronosyltransferase enzyme, common in neonates. | Metabolism pathway for detoxification/drug clearance. | Leads to Chloramphenicol toxicity (Gray baby syndrome). |
| P450 Induction | Increased activity of Cytochrome P450 enzymes. | Drug metabolism; increases drug breakdown rate. | Rifampin causes induction, reducing the effectiveness of oral contraceptives. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Antibiotic Mechanisms/Classes | Create a flow chart: 30 S vs 50 S; Gram-positive vs Gram-negative coverage. | High (Must know MOA for board questions). | Review drug tables and mnemonic devices (e.g., "MCL" for Macrolides). |
| Toxicity & Contraindications | Focus on the reason for toxicity/contraindication (e.g., Chloramphenicol -> UDPGT; Tetracycline -> Divalent Ions). | High (Common trap questions). | Use flashcards to link drug name -> specific side effect/risk group. |
| Drug Interactions | Master the P450 induction/inhibition pattern and its clinical consequence (e.g., birth control failure). | Medium-High (Integration question potential). | Practice scenarios involving multiple medications taken concurrently. |
Question pattern recognition
- Mechanism of Action: Identifying which ribosomal subunit or enzymatic step is inhibited by a given drug class.
- Toxicity/Contraindication: Recognizing the specific patient population or physiological state that makes an antibiotic dangerous (e.g., neonates, pregnant women).
- Drug Interaction: Predicting therapeutic failure due to P450 induction or altered metabolism.
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Assuming all antibiotics cover anaerobes. Only specific agents like Metronidazole and Clindamycin are reliable for anaerobic coverage, and aminoglycosides do not work against them.
🚫
Mistake 2: Confusing the indications for Chloramphenicol. While it is a potent drug, its use in neonates must be reserved for life-threatening situations (e.g., RMSF) due to severe toxicity risks.
🚫
Mistake 3: Misunderstanding P450 directionality. Remember that Rifampin induces metabolism, while Macrolides inhibit it.
Common traps
⚠️
Trap 1 (Age Restriction): Never give tetracyclines to children <8 years old due to irreversible staining of teeth and bone.
⚠️
Trap 2 (Anaerobes vs. Gram Negatives): Do not assume that because an antibiotic covers Gram-negatives, it also covers anaerobes; the coverage is distinct.
⚠️
Trap 3 (Primary vs Secondary AI): While this episode focuses on antibiotics, remember that primary adrenal insufficiency causes hyperkalemia/Type 4 RTA because aldosterone production is deficient (a common board trap).
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Autonomic Nervous System Equilibrium: Homeostatic balance requires coordination between sympathetic thoracolumbar outflow (T1–L2) and parasympathetic craniosacral outflow (CN III, VII, IX, X and S2–S4). Tissue texture abnormalities (hypertonicity, boggy edema, moisture) at specific vertebral levels reflect visceral dysfunction.
- Lymphatic Circulation & Diaphragmatic Function: The four major transverse fascial diaphragms (tentorium cerebelli, thoracic inlet, thoracoabdominal diaphragm, and pelvic floor) must move freely in synchrony with respiration to ensure efficient venous return and metabolic clearance.
- COMLEX Board Strategy: Always evaluate the anatomical spinal segment corresponding to the patient's presenting symptom. Correcting somatic dysfunctions at key transitional junctions (OA, C7–T1, T12–L1, L5–S1) improves systemic neurovascular dynamics.